Can-Fite Biopharma Ltd ADR [CANF] stock prices are down -12.92% to $0.33 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CANF shares have lost -14.51% over the last week, with a monthly amount drifted -34.47%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Can-Fite Biopharma Ltd ADR [AMEX: CANF] stock has seen the most recent analyst activity on August 11, 2017, when Maxim Group initiated its Buy rating and assigned the stock a price target of $7. H.C. Wainwright reiterated its Buy rating and increased its price target to $6 on November 30, 2015. H.C. Wainwright reiterated its recommendation of a Buy and reduced its price target to $3 on March 31, 2015. ROTH Capital downgraded its rating to Neutral for this stock on March 30, 2015, and downed its price target to $2.40. In a note dated December 29, 2014, ROTH Capital reiterated a Buy rating on this stock and revised its target price from $28 to $20.
The stock price of Can-Fite Biopharma Ltd ADR [CANF] has been fluctuating between $0.35 and $2.35 over the past year. Currently, Wall Street analysts expect the stock to reach $7.25 within the next 12 months. Can-Fite Biopharma Ltd ADR [AMEX: CANF] shares were valued at $0.33 at the most recent close of the market. An investor can expect a potential return of 2096.97% based on the average CANF price forecast.
Analyzing the CANF fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -15.95%, Pretax Profit Margin comes in at -15.71%, and Net Profit Margin reading is -15.71%. To continue investigating profitability, this company’s Return on Assets is posted at -1.14, Equity is -1.83 and Total Capital is -1.6. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3057 points at the first support level, and at 0.2805 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3546, and for the 2nd resistance point, it is at 0.3783.
Ratios To Look Out For
It’s worth pointing out that Can-Fite Biopharma Ltd ADR [AMEX:CANF]’s Current Ratio is 3.60. As well, the Quick Ratio is 3.60, while the Cash Ratio is 3.04.
